Intravenous infusion safety technology: Return on investment

Hospital Pharmacy

Volumn 44, Issue 8, 2009, Pages 680-688

  Danello, Sherry H ^a   Maddox, Ray R ^b   Schaack, Gregory J ^c  

^a Patient Care Services   (United States)

^b Clinical Pharmacy   (United States)

^c St Joseph's/Candler Health System   (United States)

Author keywords

Medication errors; Return on investment; Smart pumps

Indexed keywords

DRUG; FENTANYL; HEPARIN; INSULIN; MIDAZOLAM; MORPHINE; PROPOFOL;

ACCIDENT PREVENTION; ANAPHYLAXIS; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CONTINUOUS INFUSION; DRUG MONITORING; DRUG SAFETY; HEALTH CARE COST; HEALTH CARE QUALITY; HEART DISEASE; HUMAN; INFECTION; INFUSION SYSTEM; INTENSIVE CARE UNIT; INVESTMENT; LUNG DISEASE; MEDICATION ERROR; METABOLIC DISORDER; NEUROLOGIC DISEASE; PATIENT CONTROLLED ANALGESIA; PATIENT SAFETY; PROFIT; RECOMMENDED DRUG DOSE; RISK ASSESSMENT; SEDATION; SIDE EFFECT; STANDARDIZATION; TACHYPHYLAXIS; UNSPECIFIED SIDE EFFECT;

EID: 70349751829     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1310/hpj4408-680     Document Type: Article

References (35)

1. Committee on Quality of Health Care in America; Institute of Medicine; Kohn LT, Corrigan JM, Donaldson MS, eds. To Err Is Human: Building a Safer Health System. Washington, DC: National Academies Press; 2000.
2. Committee on Identifying and Preventing Medication Errors; Institute of Medicine; Aspden P, Wolcott J, Bootman JL, Cronenwett LR. Preventing Medication Errors: Quality Chasm Series.Washington, DC: National Academies Press; 2006.
3. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277(4):307-311.
4. Williams CK, Maddox RR. Implementation of an I.V. medication safety system. Am J Health Syst Pharm. 2005;62(5):530-536.
5. National Coordinating Council for Medication Error Reporting and Prevention. NCC MERP taxonomy of medication errors. Oakbrook Terrace, IL: National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP); 1998. http://www.ncc merp.org/pdf/taxo2001-07-31.pdf. Accessed June 23, 2009.
6. United States Pharmacopeia. Summary of Information Submitted to MEDMARX in the Year 2001: A Human Factors Approach to Understanding Medication Errors. Rockville, MD: United States Pharmacopeial Convention Inc; 2002. http://www.usp.org/pdf/EN/medmarx /2001MEDMARXSummary.pdf. Ac cessed June 30, 2009.
7. Winterstein AG, Hatton RC, Gonzalez-Rothi R, Johns TE, Segal R. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports. Am J Health Syst Pharm. 2002;59(18);1742-1749. (Pubitemid 35033912)
8. Hicks RW, Cousins DD, Williams RL. Summary of Information Submitted to MEDMARX in the Year 2002: The Quest for Quality. Rockville, MD: USP Center for the Advancement of Patient Safety; 2003.
9. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274(1):29-34.
10. Vanderveen T. IVs first - a new barcode implementation strategy. Patient Safety & Quality in Healthcare. 2006; May/June:14-20.
11. Williams CK, Maddox RR, Heape E, Richards HE, Griffiths DL, Crass RE. Application of the IV medication harm index to assess the nature of harm averted by "smart" infusion safety systems. J Pat Saf. 2006;2(3):132-139.
12. Kaushal R, Bates DW, Landrigan C, et al.Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285(16):2114-2120. (Pubitemid 32367829)
13. Ross LM, Wallace J, Paton JY. Medication errors in a paediatric teaching hospital in the UK: five years operational experience. Arch Dis Child. 2000;83 (6):492-497.
14. Data on file, Alaris Products hospital pooled data, Cardinal Health, San Diego, CA, 2006.
15. Maddox RR, Williams CK, Oglesby H, Butler B, Colclasure B. Clinical experience with patient-controlled analgesia using continuous respiratory monitoring and a smart infusion system. Am J Health Syst Pharm. 2006;63(2):157-164. (Pubitemid 43100362)
16. More on avoiding opiate toxicity with PCA by proxy. ISMP Medication Safety Alert! May 29, 2002. http:// www.ismp.org/newsletters/acutecare/arti cles/20020529.asp. Accessed June 23, 2009.
17. Safety issues with patient-controlled analgesia part I - how errors occur. ISMP Medication Safety Alert! July 10, 2003. http://www.ismp.org/ newsletters/acute care/articles/20030710.asp. Accessed June 23, 2009.
18. Safety issues with patient-controlled analgesia. ISMP Medication Safety Alert! Nurse Advise-ERR. 2005;1:1-3.
19. US Food and Drug Administration. Manufacturer and User Facility Device Experience Database (MAUDE) [database online]. January through December 31, 2004. Silver Spring, MD: US Food and Drug Administration; May 30, 2009. http://www.accessdata.fda.gov/scripts/cd rh/cfdocs/cfMAUDE/search.CFM. Accessed June 23, 2009.
20. Overdyk FJ. PCA presents serious risks [foundation newsletter]. Anesth Pat Saf. 2005;20(2):33.
21. Hicks RW, Becker SC, Cousins DD. MEDMARX Data Report: A Chartbook of Medication Error Findings from the Perioperative Settings from 1998-2005. Rockville, MD: USP Center for the Advancement of Patient Safety; 2006. http://www.usp.org/pdf/EN/medmarx /2005MEDMARXReport.pdf. Accessed June 30, 2009.
22. Weinger MB. Dangers of postoperative opioids [foundation newsletter]. Anesth Pat Saf. 2006-2007; 21(4):61-88.
23. Overdyk FJ, Carter R, Maddox RR, Callura J, Herrin AE, Henriquez C. Continuous oximetry/capnometry monitoring reveals frequent desaturation and bradypnea during patient controlled analgesia. Anesth Analg. 2007;105(2):412-418. (Pubitemid 47196421)
24. United States Pharmacopeia. Patientcontrolled analgesia pumps. USP Quality Review. September 2004. No.81. http:// www.usp.org/hqi/ practitionerPrograms /newsletters/qualityReview/qr812004-09-01.html. Accessed June 23, 2009.
25. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002;96(4):1004-1017.
26. Miner JR, Heegaard W, Plummer D. End-tidal carbon dioxide monitoring during procedural sedation. Acad Emerg Med. 2002;9(4):275-280. (Pubitemid 34274156)
27. Smetzer JL, Vaida AJ, Cohen MR, Tranum D, Pittman MA, Armstrong CW. Findings from the ISMP Medication Safety Self-Assessment for Hospitals. Jt Comm J Qual Saf. 2003;29(11):586-597.
28. US Department of Labor, Bureau of Labor Statistics. Table 30. Consumer price index for all urban consumers (CPIU): selected areas, semiannual averages, all items index. http://www.bls.gov/cpi /cpid06sv.pdf. Accessed July 2, 2009.
29. Barker KN, McConnell WE. The problems of detecting medication errors in hospitals. Am J Hosp Pharm. 1962;19 (3):360-369.
30. Barker KN, Flynn EA, Pepper GA. Observation method of detecting medication errors. Am J Health Syst Pharm. 2002;59(23):2314-2316.
31. Bates DW, Vanderveen T, Seger D, Yamaga C, Rothschild JD. Variability in intravenous medication practices: implications for medication safety. Jt Comm J Qual Saf. 2005;31(4):203-210.
32. The Joint Commission. 2007 national patient safety goals critical access hospital version manual chapter, including implementation expectations. Goal 3B: standardize and limit the number of drug concentrations used by the organization. http://www.jointcommission.org/NR/rdo nlyres/1AD5F8C0-CB2D-46F0- 8052-C2AD126C1377/0/07-cah-npsgs.pdf. Accessed June 23, 2009.
33. Maddox RR. ICU sedation with propofol: measuring and reducing variation. Presented at: Sedation Therapy: Improving Safety and Quality of Care. The Sixth Conference, Center for Medication Safety and Clinical Improvement; November 17-18, 2005; San Diego, CA. http://www. cardinal.com/clinicalcenter/materials/ con ferences/SedationProceedings.pdf. Ac cessed June 23, 2009.
34. Riker RR, Fraser GL. Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy. 2005;25(5)(pt 2):8S-18S.
35. Murray MJ, Cowen J, DeBlock H, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30(1):119-141.